Trials in development
Trial suggestions are submitted by our members. These are listed below and are atvarious stages of development.
The UK DCTN operates a traffic light system for trials in development.
Red – Idea approved in principle but not yet in development through the network or currently on hold.
Amber – Approved by the Steering Committee and currently being developed
Green – Ready for submission to funding bodies/ seeking funding
Study title/type
Lead
Status
Stage
Treatments for Pyoderma Gangrenosum
Dr Philip Hampton
SPOT-IT Skin Cancer Prevention
Dr C Harwood
Applied for funding
OPINION - Psychological interventions for people with vitiligo
Dr V Eleftheriadou
Seeking funding
SPRINTR-UK - Can oral nicotinamide reduce the incidence of keratinocyte skin cancer in organ transplant recipients?
Dr Rubeta Matin
POWER - Oestrogen for Lichen sclerosus
Dr Jaskiran Azad
In development
EXCISE - Do prophylactic antibiotics reduce risk of wound infection following skin cancer surgery
Dr Rachel Abbott & Dr Aaron Wernham
In low-risk BCC, is clinic-based diagnostic punch biopsy followed by observation, not inferior to standard pragmatic ablative treatment, in terms of skin cancer specific quality of life?
Jeremy Rodriguez and Rubeta Matin
What is the effect of an adjunctive ‘Walk and Talk’ intervention for people with psoriasis on social connectedness?
Sharleen Hill and Sandy McBride
Can we manage keratoacanthoma better? Can we defer surgery to improve outcomes?
Dr Saleem Taibjee
On hold
CANVAS - Are absorbable sutures non-inferior to non-absorbable sutures
Dr Aaron Wernham & Dr David Veitch
Email: UKDCTN@nottingham.ac.uk
Browser does not support script.